Showing results (221-230 of 254) with videos related to
Sort By:
Pageof 26
Nature Communications|September 25, 2023
A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activatorsYi-Cheng Chang, Hsiao-Lin Lee, Wenjin Yang, et al.The Lancet. Diabetes & Endocrinology|May 17, 2015
Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trialSayeed Ikramuddin, Charles J Billington, Wei-Jei Lee, et al.Obesity Surgery|October 27, 2016
National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m<sup>2</sup>)Keong Chong, Sayeed Ikramuddin, Wei-Jei Lee, et al.Antioxidants (Basel, Switzerland)|April 3, 2021
A Novel ALDH2 Activator AD-9308 Improves Diastolic and Systolic Myocardial Functions in Streptozotocin-Induced Diabetic MiceHsiao-Lin Lee, Siow-Wey Hee, Chin-Feng Hsuan, et al.Obesity Surgery|August 23, 2023
Roux-en-Y and One-Anastomosis Gastric Bypass Surgery Are Superior to Sleeve Gastrectomy in Lowering Glucose and Cholesterol Levels Independent of Weight Loss: a Propensity-Score Weighting AnalysisYi-Cheng Chang, Chih-Neng Hsu, Keong Chong, et al.Journal of Biomedical Science|February 21, 2023
ER ribosomal-binding protein 1 regulates blood pressure and potassium homeostasis by modulating intracellular renin traffickingChu-Hsuan Chiu, Chin-Feng Hsuan, Shih-Hua Lin, et al.Scientific Reports|February 15, 2023
A randomized trial on the effect of transcutaneous electrical nerve stimulator on glycemic control in patients with type 2 diabetesJin-Ying Lu, Horng-Yih Ou, Chung-Ze Wu, et al.Diabetes|October 31, 2009
Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studiesChris R Cardwell, Lars C Stene, Geir Joner, et al.Diabetologia|September 10, 2013
Trans-ethnic fine mapping identifies a novel independent locus at the 3' end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese populationJane Z Kuo, Wayne Huey-Herng Sheu, Themistocles L Assimes, et al.JAMA Network Open|April 30, 2021
Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical TrialLee-Ling Lim, Eric S H Lau, Amy W C Fu, et al.Pageof 26